SPRO vs WST · P/E 9.6, rev $258.0K vs P/E 35, rev $1.72B
Spero Therapeutics Inc (SPRO) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
Spero Therapeutics Inc (SPRO) is a biotechnology company listed on NASDAQ.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported SPRO revenue for 2026-06-30 was $258.0K. Net income was -$16.8M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
SPRO currently screens at market cap $149.5M and trailing P/E 9.6. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the SPRO and WST stock pages for the full models.
Not investment advice.